3 Medtech Companies with Higher Future Share Prices

Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)

Should you invest $1,000 in Boston Scientific right now?

Before you consider Boston Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Boston Scientific wasn't on the list.

While Boston Scientific currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Companies Mentioned in This Article

Company	MarketRank™	Current Price	Price Change	Dividend Yield	P/E Ratio	Consensus Rating	Consensus Price Target
Intuitive Surgical (ISRG)	4.7768 of 5 stars	$372.56	-0.4%	N/A	67.25	Moderate Buy	$396.17
DexCom (DXCM)	4.9585 of 5 stars	$127.35	+1.2%	N/A	82.16	Moderate Buy	$141.67
Boston Scientific (BSX)	4.398 of 5 stars	$71.77	-1.0%	N/A	60.31	Moderate Buy	$75.09

Compare These Stocks Add These Stocks to My Watchlist

About Thomas Hughes

tmhughes.writeon@gmail.com

Contributing Author

Technical and Fundamental Analysis

Experience

Thomas Hughes has been a contributing writer for MarketBeat since 2019.

Areas of Expertise

Technical analysis, the S&P 500; retail, consumer, consumer staples, dividends, high-yield, small caps, technology, economic data, oil, cryptocurrencies